Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Healthtrust
Johnson and Johnson
QuintilesIMS
Argus Health
US Department of Justice
Colorcon
Mallinckrodt
Fuji
Deloitte

Generated: August 16, 2017

DrugPatentWatch Database Preview

FEMTRACE Drug Profile

« Back to Dashboard

Which patents cover Femtrace, and what generic Femtrace alternatives are available?

Femtrace is a drug marketed by Apil and is included in one NDA. There are three patents protecting this drug.

This drug has eleven patent family members in ten countries.

The generic ingredient in FEMTRACE is estradiol acetate. There are seventy-five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the estradiol acetate profile page.

Summary for Tradename: FEMTRACE

Patents:3
Applicants:1
NDAs:1
Bulk Api Vendors: see list63
Patent Applications: see list226
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FEMTRACE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apil
FEMTRACE
estradiol acetate
TABLET;ORAL021633-001Aug 20, 2004DISCNYesNo► Subscribe► SubscribeY ► Subscribe
Apil
FEMTRACE
estradiol acetate
TABLET;ORAL021633-003Aug 20, 2004DISCNYesNo► Subscribe► SubscribeY ► Subscribe
Apil
FEMTRACE
estradiol acetate
TABLET;ORAL021633-002Aug 20, 2004DISCNYesNo► Subscribe► SubscribeY ► Subscribe
Apil
FEMTRACE
estradiol acetate
TABLET;ORAL021633-003Aug 20, 2004DISCNYesNo► Subscribe► SubscribeY ► Subscribe
Apil
FEMTRACE
estradiol acetate
TABLET;ORAL021633-001Aug 20, 2004DISCNYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: FEMTRACE

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)03055495► Subscribe
Canada2470703► Subscribe
China1564689► Subscribe
China1273141► Subscribe
Israel160797► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: FEMTRACE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
156Luxembourg► SubscribePRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211
C0018France► SubscribePRODUCT NAME: ESTRADIOL VALERATE; DIENOGEST; NAT. REGISTRATION NO/DATE: NL35170 20081210; FIRST REGISTRATION: BE327792 20081103
0814Netherlands► SubscribePRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
2009004Lithuania► SubscribePRODUCT NAME: ESTRADIOLI VALERAS + DIENOGESTUM; NAT. REGISTRATION NO/DATE: LT/1/09/1512/001, 2009 04 06 LT/1/09/1512/002, 2009 04 06 LT/1/09/1512/003 20090406; FIRST REGISTRATION: BE 327792 20081103
2006 00038Denmark► SubscribePRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Healthtrust
UBS
Colorcon
Citi
Fuji
Chinese Patent Office
Johnson and Johnson
Queensland Health
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot